Waystar (NASDAQ:WAY) Rating Increased to Strong-Buy at KeyCorp

KeyCorp upgraded shares of Waystar (NASDAQ:WAY) to a strong-buy rating in a report issued on Wednesday morning,Zacks.com reports.

WAY has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Waystar from $42.00 to $37.00 and set a “buy” rating for the company in a research note on Thursday, March 12th. Bank of America lowered their price objective on shares of Waystar from $45.00 to $38.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Raymond James Financial reiterated a “strong-buy” rating and issued a $32.00 target price on shares of Waystar in a report on Thursday, April 30th. Weiss Ratings cut Waystar from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. Finally, Citigroup cut their price objective on Waystar from $35.00 to $30.00 and set a “buy” rating on the stock in a report on Tuesday, May 5th. Four research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Waystar has a consensus rating of “Buy” and a consensus price target of $35.36.

Waystar Trading Up 9.5%

WAY opened at $23.46 on Wednesday. The stock has a market capitalization of $4.50 billion, a PE ratio of 35.01, a P/E/G ratio of 0.84 and a beta of 0.08. Waystar has a one year low of $17.26 and a one year high of $41.47. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.76 and a current ratio of 1.76. The business’s 50 day moving average price is $20.24 and its 200 day moving average price is $24.65.

Waystar (NASDAQ:WAY) last posted its earnings results on Wednesday, April 29th. The company reported $0.42 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.03. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The company had revenue of $313.87 million for the quarter, compared to the consensus estimate of $311.74 million. During the same quarter in the previous year, the business earned $0.32 earnings per share. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. As a group, equities research analysts expect that Waystar will post 1.46 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Royal Bank of Canada boosted its stake in shares of Waystar by 11.3% in the 1st quarter. Royal Bank of Canada now owns 21,609 shares of the company’s stock valued at $808,000 after buying an additional 2,195 shares during the period. AQR Capital Management LLC acquired a new stake in shares of Waystar in the 1st quarter valued at $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Waystar by 91.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company’s stock worth $1,753,000 after purchasing an additional 22,364 shares during the last quarter. NewEdge Advisors LLC purchased a new stake in shares of Waystar during the 1st quarter worth $234,000. Finally, Goldman Sachs Group Inc. grew its stake in shares of Waystar by 13.4% during the first quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company’s stock worth $27,918,000 after purchasing an additional 88,256 shares in the last quarter.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.